Dexrazoxane
Active substance: dexrazoxane
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DEXRAZOXANE HYDROCHLORIDE 250 mg/1
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DEXRAZOXANE HYDROCHLORIDE · 250 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2afd-721d-b284-5e3223187d74,01a1208c-2afd-7e41-b284-5e3223fcbc24,01a1208c-2b14-7ee4-8dd0-21bf69a74cac,01a1208c-a4fa-7f7d-ba97-d21415ad0b00,01a1208d-bbb5-75b6-908c-adda0da3a0d8;count=11 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0143-9247
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0143-9247 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0143-9247 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0143-9247 · Verified 2026-10-09 · open in source